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Abstract
Background: The binding of viral-specific antibodies to cell-surface antigens usually results in
down modulation of the antigen through redistribution of antigens into patches that subsequently
may be internalized by endocytosis or may form caps that can be expelled to the extracellular
space. Here, by use of confocal-laser-scanning microscopy we investigated the kinetics of the
modulation of respiratory syncytial virus (RSV) antigen by RSV-specific IgG. RSV-infected human
epithelial cells (HEp-2) were incubated with anti-RSV polyclonal IgG and, at various incubation
times, the RSV-cell-surface-antigen-antibody complexes (RSV Ag-Abs) and intracellular viral
proteins were detected by indirect immunoflourescence.
Results: Interaction of anti-RSV polyclonal IgG with RSV HEp-2 infected cells induced
relocalization and aggregation of viral glycoproteins in the plasma membrane formed patches that
subsequently produced caps or were internalized through clathrin-mediated endocytosis
participation. Moreover, the concentration of cell surface RSV Ag-Abs and intracellular viral
proteins showed a time dependent cyclic variation and that anti-RSV IgG protected HEp-2 cells
from viral-induced death.
Conclusion: The results from this study indicate that interaction between RSV cell surface
proteins and specific viral antibodies alter the expression of viral antigens expressed on the cells
surface and intracellular viral proteins; furthermore, interfere with viral induced destruction of the
cell.
Background
Antibody-induced modulation of antigen is a complex
biological phenomenon closely resembling other recep-
tor-ligand interactions. Following exposure to specific
antibodies, surface antigens are usually redistributed on
the cell surface and are internalized or expelled into the
extracellular medium [1,2]. These phenomena have been
widely reported in virus systems [3-5], the best studied
being an alpha herpes; in pseudorabies [6-9]. In that sys-
tem, following exposure to specific antibodies, cell-sur-
face antigens are usually redistributed with the
membrane-bound viral glycoproteins aggregating to form
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cells, the patches subsequently polarize to one area of the
cell, thus producing caps that are shed into the extracellu-
lar space [6-9]. In contrast, in monocytes, glycoprotein
patches do not form caps, but instead collect in regions of
the plasma membrane which are specialized for internal-
ization through clathrin-coated pits. After the clathrin
coated pits are introduced into the cell, the antibody-anti-
gen complexes are degraded and the glycoproteins are
directed back to the plasma membrane [8-10].
Respiratory syncytial virus (RSV) is an enveloped pneu-
movirus classified within the Paramyxoviridae family. Its
genome encodes two non-structural and nine structural
proteins, three of which are transmembrane surface glyc-
oproteins: The G protein is involved in the virus attach-
ment; the F protein mediates fusion of virus with cell
membranes [11], and SH protein inhibits TNF-alpha sig-
nalling [12]. Cells infected with RSV can fuse with adja-
cent cells resulting in giant multinucleated syncytium,
polykaron formation besides being cytophatic favors virus
spread [11].
Worldwide, RSV is the most important viral pathogen of
serious lower-respiratory tract illness in infants and young
children. RSV infects nearly 70% of infants in their first
year of life; by the age of 24 months old virtually all chil-
dren will have been infected at least once and about half
will have experienced at least two infections [11,13,14].
RSV also causes significant disease in adults (especially
those in contact with children); it is also regarded as an
important cause of serious illness/morbidity occurring in
the elderly [15] and in patients with a compromised
immune system [16]. Severe RSV disease appears to be
linked to an unbalanced immune response [14,17-19], it
has also been associated with asthma [20-23] and acute
exacerbations of chronic obstructive pulmonary disease
(COPD) [24-26]. The mechanisms, by which this infec-
tion leads to airway dysfunction that persists long after the
acute disease has been resolved, are not well defined.
However, involvement of RSV persistence in long term
respiratory problems has been suggested [18-20,24-29].
Individuals previously infected with RSV can be subse-
quently re-infected (within months) with either an identi-
cal or antigenically closely related virus despite the
presence of serum antibodies [11,13,29]. RSV persistence
has been postulated as a reservoir for viral transmission
and re-infection [18,26]. Both the innate and adaptive
immune responses participate in clearing the virus and
the pathogenesis associated with infection [11,14,17-
20,25,26]. In temperate climates, annual RSV outbreaks
occur predictably from late fall to early spring [30,31],
The current study was designed to examine whether RSV-
cell-surface-antigen-antibody complexes (RSV Ag-Abs) in
epithelial cells undergo aggregation into patches that sub-
sequently either form caps or are internalized through
endocytosis. Furthermore, kinetic assays were used to
determine the concentration level and fate of viral pro-
teins in RSV-infected cells that had been incubated with
anti-RSV antibodies.
By determining the RSV Ag-Abs in plasma membrane and
viral proteins in the cytoplasm, we investigated the effect
of the presence of RSV-specific IgG on infected epithelial
cells over a period of time (1 hour) and on the viability of
these cells. Here, we present evidence that anti-RSV IgG
induced redistribution of cell surface viral glycoproteins
and that internalization of RSV Ag-Abs was partially
inhibited by incubation in hypertonic medium, thus sug-
gesting the participation of a clathrin-mediated mecha-
nism. We also observed a time-dependent, cyclic
fluctuation in the concentration of RSV Ag-Abs in cell sur-
face and in intra-cellular viral proteins. Moreover, anti-
RSV IgG protected HEp-2 cells from viral-induced cell
death.
Methods
All reagents were from Sigma, unless otherwise specified
Virus and cells
Human epidermoid carcinoma larynx cell line HEp-2
from our laboratory (originally from ATCC) was grown in
Dulbecco's modified medium (D-MEM; GIBCO BRL
12100-038) which was determined to be mycoplasma
free by using a mycoplasma detection kit (Boheringer
Mannheim). Long strain RSV has been used as the proto-
type virus in our laboratory for over ten years. The proce-
dures for propagating cells and viruses and for assaying
viral infectivity have been described elsewhere [32].
Anti-RSV antibodies
Polyclonal anti-RSV sera were obtained in our laboratory
from male New Zealand rabbits after three intramuscular
immunizations with RSV (1 × 106 TCID50/ml; 400 µg pro-
tein/ml) that had been purified by linear sucrose gradient.
Pre-immune sera was obtained from the rabbits before
immunization. Anti-RSV serum characteristics were evalu-
ated by its neutralization activity in viral infectivity [33],
and by the presence of antibodies against RSV proteins.
The specific antibodies against viral proteins were deter-
mined by western blot assays with the purified RSV virion
utilized to immunize the rabbits. Proteins with apparent
molecular weight from 45 to 240 kDa were detected. The
presence of RSV glycoproteins was confirmed by flow
cytometry assays to determine cell-surface RSV proteins in
infected HEp-2 cells [34].Page 2 of 9
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Harlow and Lane, with some modifications [35]. Briefly,
adding the serum through a protein-A sepharose column
after keeping the column overnight a 4°C. IgG were eluted
with acetic acid 0.1 M and NaCl 0.15 M and the fractions
of 1 ml were collected in tubes with 100 µl of Tris-HCl
buffer 8.0. Fractions with OD Of 0.9 to 2.07 at 280 nm
were collected and the protein content was determined by
Lowry. Polyclonal serum with viral infectivity neutraliza-
tion titer of, 1.2 × 104 TCID50/ml per 30 µg protein/ml was
used.
Visualization of RSV antigen
HEp-2 cells (1 × 104) that had been grown on glass cover
slips, previously treated with poly-L lysine (1 µg/ml at
room temperature (RT)) and washed with phoshate-buff-
ered saline (PBS), for 30 min., were infected with RSV at a
multiplicity of infection (m.o.i.) of 50 (12 h; 37°C; 5%
CO2-air) and thereafter washed in PBS. Infected cells were
permeabilized and fixed with cold methanol (5 min) and
cold acetone (30 sec) and the viral antigen was visualized
by indirect immunofluorescence by using goat anti-RSV
(MAB 858-1 Chemicon, Temecule, CA) as first antibody
and rabbit anti-goat fluorescence conjugate (61–1611
Zymed, South San Francisco, CA) as second antibody, as
previously described [32]. Fluorescence-labelled proteins
were examined by confocal microscopy. As control, mock-
infected cells were used.
Visualization of RSV Ab-Ags on the cell surface
To RSV-infected cells (three cover slips), anti-RSV IgG,
diluted 1:5 in D-MEM containing 1% glutamine, was
added to cover the cell monolayer and the mixture was
incubated at 37°C. At 0, 10, 20, 30, 40, 50, or 60 minutes
of incubation, cell samples were taken, then washed in
PBS to remove excess of anti-RSV IgG, and fixed with 4%
paraformaldehyde in PBS. The RSV Ag-Abs was visualized
by indirect immunofluorescence as previously described.
Controls were, RSV-infected cells (three cover slips) incu-
bated with pre-immune polyclonal IgG, mock-infected
cells (three cover slips) incubated with anti-RSV IgG and
(three cover slips) with pre-immune polyclonal IgG.
Detection of intracellular RSV proteins
Cells grown in cover slips were infected and incubated at
37°C with anti-RSV IgG, at 0, 10, 20, 30, 40, 50, or 60
minutes washed permeabilized and fixed. Then intracellu-
lar viral proteins were detected by adding anti-RSV IgG
and incubated 1 h at 37°C. Afterwards, cells were washed
and viral proteins visualized by indirect immunofluores-
cence as described. Controls were as described for visuali-
zation of RSV Ab-Ags on the cell surface.
Inhibition of internalization of RSV Ag-Abs by hypertonic incubation
The sucrose inhibition assay was used [36]. Briefly
infected cells, which had been grown on cover slips as
described, were incubated (30 min; 37°C) with D-MEM
supplemented with 2% fetal bovine serum (FBS) and 0.3
M sucrose. Then, anti-RSV IgG was added and were incu-
bated in D-MEM containing 2% FBS and 0.3 M sucrose. At
various incubation times (0, 10, 20, 30, 40, 50, or 60
min), cells were permeabilized and fixed, then after anti-
RSV IgG was added and intracellular RSV proteins were
determined as described above.
Confocal laser scanning microscopy
Fluorescent samples were examined in a Bio-Rad MRC
600 confocal laser scanning system that was linked to an
Axioskop Zeiss microscope with Plan-Neuflour 40×/
0.75P H2 objective. Krypton-argon laser light was used to
excite fluorescein isothiocyanate (FITC; 488 nm line) with
emission BHS filter. Data were processed with Bio-Rad
CoMOS with Z-step of 1.08 nm.
Cell viability
To infected HEp-2 cells, anti-RSV IgG was added, and cell
viability was determined at 2, 24, 48, and 72 h of incuba-
tion. Sterile 0.2% ethylenediamine tetra acetate (EDTA) in
0.9% saline was added to each cell monolayer; after incu-
bation (15 min), the cells were suspended in D-MEM con-
taining 2% FBS and trypsin (5 µg/ml). Trypan blue
solution was added to the cell suspension and the viable
cells were counted by light microscopy. As controls, both
infected cells incubated with pre-immune IgG and mock-
infected cells incubated with anti-RSV IgG were used.
Results
RSV proteins in infected HEp-2 cells
RSV proteins, present in viral infected HEp-2 cells, were
visualized in permeabilized cells by indirect immunoflu-
orescence, at various times after infection. We observed
(results not shown) that viral proteins could be visualized
at 6 to 8 h post infection (p.i., fluorescence intensity of 1–
2); however, for 90 to 95% of the cells, a fluorescence
intensity of 2–3 was observed at 12 h p.i. (Fig. 1), yet nei-
ther cell destruction nor infective extracellular virus was
found. At longer incubation times, fluorescence intensity
increased, and cell destruction was evident; therefore, sub-
sequent experiments were done with cells infected for 12
h p.i.
Anti-RSV IgG induced redistribution of viral glycoproteins 
on the surface of infected cells
The interaction of RSV-specific IgG with cell surface RSV
glycoproteins was determined by examining the binding
of anti-RSV IgG to infected cells at 0, 10, 20, 30, 40, 50, or
60 minutes of incubation.Page 3 of 9
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brane of infected cells were visualized in parformalde-
hyde-fixed cells by indirect immunofluorescence assay,
the fluorescently labelled cells were examined by confocal
microscopy. Because the cells were not permeabilized, the
labelled antibody detected only anti-RSV IgG antibody
bound to glycoproteins on the cell surface (Fig. 2). Initial
experiments were done at m.o.i. of 10 to 20; however,
because the anti-RSV IgG induced rearrangement of RSV
Ag-Abs was best observed at higher m.o.i. (50) therefore
assays were done at that multiplicity.
The presence of fluorescent RSV glycoproteins on the cell
surface was scored in the following manner: rim, when
the florescence was homogenously distributed; patch,
when the proteins were in randomly distributed aggre-
gates; and caps, when the patches were polarized in a site
on the cell. The intensity of fluorescence observed in the
images from the immunofluorescence assays was arbitrary
expressed, with 1 as the lowest intensity and 3, the high-
est. Results were obtained by examining the distribution
of fluorescence on at least 100 cells. All assays were run
independently at least three times.
In the 0-minute-incubation (anti-RSV IgG control) assay,
antibody-bound viral glycoproteins were observed as a
rim, with fluorescence intensity of 1 (Fig. 2A). After 10-
minute incubation with antibody, RSV Ag-Abs complexes
were aggregated as randomly distributed patches with flu-
orescence intensity of 2 (Fig. 2B). At 20-minute incuba-
tion, the fluorescence intensity increased to 3 and the
antibody-glycoprotein complexes were found to be rear-
ranged as caps on the cell surface; however, areas without
detectable RSV proteins were present (Fig. 2C).
Confocal laser scanning image of the distribution of viral glyc-oproteins on cell surface of epithelial cellsFigur  2
Confocal laser scanning image of the distribution of 
viral glycoproteins on cell surface of epithelial cells. 
HEp-2 cells had been infected at m.o.i. of 50 for 12 h then 
incubated with anti-RSV IgG and fixed, at different times, 
with paraformaldehyde. Kinetics of viral proteins determined 
according to material and methods. Incubation time (min):A) 
0, control; B) 10;C) 20; D) 30; E) 40; F) 50; and G) 60. Images 
of fluorescein-labelled proteins: left with UV light, right with 
visible and UV light.
Indirect immunofluorescence of RSV antigen in infected epi-thelial cellsFigure 1
Indirect immunofluorescence of RSV antigen in 
infected epithelial cells. Viral proteins in HEp-2 cells, 
which had been infected at m.o.i. of 50 for 12 h permeabi-
lized and fixed with acetone and cold methanol, were visual-
ized by indirect immunofluorescence with an epifluorescent 
microscope. First antibody: goat anti-RSV; second antibody: 
rabbit anti-goat. A) RSV-infected cells; B) mock-infected cells.Page 4 of 9
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and fluorescence intensity decreased, with the fluores-
cence (intensity of 2) being once again observed as rim
(Fig. 2D). In the 40-minute-infection assay, the fluores-
cence was found basically on the rim, with intensity of 1
(Fig 2E). On further incubation (50 min), cells showed an
intensity of 2, with antibody-bound glycoproteins as rim,
with a few patches (Fig. 2F). In the 60-minute-incubation
assay, the fluorescence had increased to an intensity of 3
and showed the viral proteins with antibody arranged as
rim (Fig. 2G). Thus, over the course of the incubation,
redistribution of viral glycoproteins varied and a cyclic
fluctuation of RSV Ag-Abs concentration was observed.
Intracellular RSV proteins concentration fluctuates with 
cyclic pattern with respect to incubation time
After establishing that anti-RSV IgG had induced an incu-
bation-time-dependent fluctuation in the concentration
of cell-surface RSV Ag-Abs, we decided to determine
whether a similar effect would occur in intracellular viral
proteins, therefore, anti-RSV IgG was added to permeabi-
lized cells and observed by indirect immunoflourescence.
Results were obtained by examining the distribution of
fluorescence on at least 100 cells. All assays were run inde-
pendently at least three times.
At time 0, the cytoplasm of permeabilized infected cells
(Fig. 3A) was fluorescent (intensity of 1), implying that
viral proteins were present. An increase in concentration
of intra-cellular labelled proteins was evident after 10
minutes of incubation with antibody (intensity of 3) (Fig.
3B), suggesting that RSV Ag-Abs were internalized. On fur-
ther incubation (20 minutes), the fluorescence intensity
was found to be diminished (intensity of 1, Fig. 3C). At 30
minutes (Fig. 3D), the labelled proteins (flourescence
intensity 2) were localized in cytoplasm areas, although
cells without labelled proteins were observed.
At 40 minutes, a clear reduction in the concentration of
viral proteins was evident, as the fluorescence was negligi-
ble (Fig. 3E), whereas a noteworthy increase (intensity 3,
Fig. 3F) in the content of labelled RSV intracellular viral
proteins was observed at 50-minute incubation. Finally, at
60 minutes, the protein concentration decreased and the
labelled RSV proteins were localized in some areas of the
cytoplasm (Fig. 3G). Moreover, infected cells without
detectable labelled proteins were observed in samples
from 20- to 60-minute incubation. These data show a
time-dependent, cyclic fluctuation in the content of intra-
cellular RSV proteins.
Clathrin-dependent endocytosis contributed to 
internalization of RSV Ag-Abs
Our results showed that anti-RSV IgG incubation induced
the removal and re-appearance of intracellular viral pro-
Confocal laser scanning image of intracellular RSV proteinsFigure 3
Confocal laser scanning image of intracellular RSV 
proteins. HEp-2 cells had been infected and then incubated 
for various times with anti-RSV IgG were permeabilized, 
fixed with acetone and methanol and anti-RSV added. The 
kinetics of intracellular viral proteins was determined as 
described in material and methods.Page 5 of 9
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related to caps expelled into the extracellular space or to
internalization of antigen-antibody complexes. Internali-
zation of receptor-ligand complexes (endocytosis) is
mediated mainly by clathrin-coated pits, regions of the
cell-surface membrane, which are specialized in the inter-
nalization process. Receptor-ligand complexes on the cell
membrane accumulate in these regions [37]. Therefore,
we decided to determine whether internalization of RSV
Ag-Abs may be associated with clathrin-dependent endo-
cytosis.
The strategy consisted of inhibition of receptor-mediated
endocytosis by exposing the cells to hypertonic medium
containing sucrose. Clathrin-coated pits derived from
clathrin-coated vesicles are not formed in hypertonic
medium [38]. To this end, infected cells were incubated
with anti-RSV IgG anti-RSV in hypertonic sucrose medium
for different times (0, 10, 20, 30, 40, 50, or 60 min), and
then to permeabilized fixed cells, anti-RSV IgG was added
and analyzed by confocal microscopy.
As shown in Figure 4A (0 min), the characteristic epithe-
lial cell morphology was evident and the cytoplasm was
covered with fluorescently labelled viral proteins (inten-
sity of 3), implying that viral proteins were homogenously
distributed in the cytoplasm. Cell morphology changed
after incubation in hypertonic medium: The cells became
round and the concentration of viral proteins and their
intra-cellular localization varied with incubation time.
Furthermore, between 0 minutes and subsequent incuba-
tion times, a marked drop in the concentration of labelled
proteins and in the fluorescence intensity were observed
(Fig. 4A to 4G).
At 10-minute incubation, intracellular fluorescently
labelled proteins were localized in one area of the cyto-
plasm of the rounded cells; patches with fluorescence
(intensity of 1) were distributed randomly (Fig. 4B). At
20-minute incubation, a decrease in the concentration of
RSV intracellular proteins was evident and the fluores-
cently labelled proteins (intensity of <1) were localized in
patches and cells without detectable fluorescently labelled
proteins were present (Fig. 4C). At 30-minute incubation,
the content of fluorescently labelled viral proteins (inten-
sity of 1) increased (Fig 4D). At 40-minute incubation, a
noticeable decrease in fluorescent proteins was observed
(Fig 4E); however, slightly higher fluorescence intensity
was observed in the samples from the 50 (Fig. 4F) and 60-
minute (Fig. 4G) incubations.
Viral proteins were continually present throughout the
assays, suggesting that either clathrin-mediated endocyto-
sis was inhibited or viral protein synthesis de novo took
place. During the assays, the concentration of viral pro-
Kinetics of intracellular RSV proteins in cells incubated in hyp rtonic mediumF gu e 4
Kinetics of intracellular RSV proteins in cells incu-
bated in hypertonic medium. HEp-2 cells had been 
infected with anti-RSV IgG and then were incubated for dif-
ferent times in sucrose medium permeabilized and fixed, in 
acetone and methanol. Confocal laser scanning was used to 
obtain images of intracellular viral proteins visualized as 
described in Figure 3.Page 6 of 9
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nounced than that in the former determinations (Fig. 2
and 3).
Anti-RSV IgG protects HEp-2 infected cells from viral 
induced death
To evaluate whether the presence of anti-RSV IgG has an
effect on cell viability, RSV- and mock-infected HEp-2
cells were incubated with either anti-RSV IgG or with IgG
from pre-immune serum and the cell viability was deter-
mined at 2, 24, 48 and 72 h p.i. As control, mock-infected
cells were incubated with anti-RSV IgG and pre-immune
IgG.
Cell viability differed in infected cells incubated with anti-
RSV IgG or with IgG from pre-immune serum. Viable-cell
density remained constant when RSV-specific immu-
noglobulins were used; in contrast, in infected cells incu-
bated with non-immune IgG, the viability of the HEp-2
cells was reduced and syncytia was observed (results not
shown). In comparison to the value obtained at 2 h p.i.,
the cell survival at 48 and 72 h p.i. was reduced to 6.5%
and 1.45%, respectively. No cell viability change was evi-
dent in mock-infected HEp-2 cells incubated with either
anti-RSV IgG or pre-immune IgG. The data suggest that
anti-RSV polyclonal IgG protected infected cells from
viral-induced death.
Discussion
In this report, we determined the effect of incubation RSV
infected epithelial cells with polyclonal RSV IgG on
expression and localization of viral proteins and cell via-
bility. Kinetics of cell-surface viral glycoproteins and intra-
cellular viral proteins was monitored through confocal
microscopy and cell viability determined by trypan blue
exclusion.
Our data show that the binding of specific antibodies to
RSV glycoproteins anchored to the plasma membrane of
human epithelial cells led to their redistribution and
aggregation (Fig 2). Subsequently, complexes of aggre-
gated viral glycoproteins with bound antibody became
clustered in patches (Fig. 2B) that then formed caps (Fig.
2C) with concomitant fluctuations on RSV Ag-Abs con-
centration. (Fig. 2).
The lower concentration of RSV Ag-Abs on cell surface can
be explained through cap formation, with subsequent
release to the extracellular medium or by endocytosis of
RSV Ag-Abs. Reduction of RSV Ag-Abs concentration on
the cell-membrane was evidenced at both 30 and 50 min-
utes of incubation with anti-RSV IgG (Fig. 2C and 2E)
implying that RSV Ag-Abs loss was done, either by caps
being expelled to the extracellular space or patches being
internalized by endocytosis (Fig. 4).
The interpretation that caps were released into the
medium was supported by the simultaneous presence of
cells with caps and areas without detectable viral glyco-
proteins (Fig. 2C). This observation agrees with reports for
pseudorabies virus in which 17% of the caps were found
to have been spontaneously expelled into the extra-cellu-
lar space, thus leaving behind cells with the above-men-
tioned characteristics [7]. However, with the
methodology we used, it was not possible to conclude
that caps were extruded. Therefore, studies are in progress
to obtain definitive data.
Our data, obtained by incubation in hypertonic media,
showed that the concentration of intracellular viral pro-
teins decreased over the course of the determinations,
thereby suggesting that endocytosis through clathrin-
mediated mechanism was inhibited (Fig. 4). The remain-
ing fluorescein-labelled viral proteins present in the cyto-
plasm during these assays (Fig. 4B to 4D) might have been
due to protein synthesis de novo and/or RSV Ag-Abs inter-
nalized through a mechanism(s) different from clathrin-
mediated endocytosis.
Protein synthesis de novo is particularly considered
because, throughout the course of these experiments, we
observed that infected cells incubated with anti-RSV IgG
were protected from viral-induced death. This observation
was confirmed through comparative cell-survival determi-
nations between infected HEp-2 cells incubated either
with anti-RSV IgG or with pre-immune IgG. The loss of
cell- surface viral glycoproteins during culturing RSV
infected cells for longer than 72 h in the presence of anti-
RSV IgG might explain the lack of syncytia formation and
hence avoid death of the cell [11].
The increase in RSV Ag-Ab concentration may be
explained as resulting from the internalization of the RSV
Ag-Abs, with subsequent dissociation of the complexes
and recycling of the liberated viral antigen back to the cell
surface [37] and/or of synthesis de novo of viral proteins
Our data suggest that in the human epithelial cell line we
used both caps formation and endocytosis took place
(Fig. 2 and 3). In contrast in pseudorabies virus capping
or internalization initiated by cell-surface protein-specific
antibody interaction depends on the cell type [5,6],
Although viral proteins on the cell plasma membrane
were detected at m.o.i. of 10 to 20, the glycoprotein-anti-
body complexes were clearly observable as patches at
higher multiplicity, implying that a defined content of
RSV proteins was required for clustering into patches. This
observation is similar to that of reports on monocytes
infected with pseudorabies virus, in which glycoproteinPage 7 of 9
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imal threshold size [6].
During consecutive assays, cell-surface- and intracellular-
protein concentrations fluctuated in a cyclic manner, thus
suggesting a continued removal and replacement of cell-
surface and intracellular proteins. In the current work,
determination was made at 10-minute intervals; however,
by using either shorter or longer time intervals, the fluctu-
ation cycles in the concentration of viral-protein-antibody
complexes may be optimized.
Exactly how RSV Ag-Abs initiate the redistribution proc-
ess, in capping or in internalization, is not fully under-
stood; however, in the alphaherpesvirinae family has been
reported that specific tyrosine family of motifs (YXXPHI;
Y standing for tyrosine, X for any aminoacid and PHI for
a hydrophobic residue), in the cytoplasmic tails of the
viral transmembrane glycoproteins activate clathrin-
mediated endocytosis [39]. Therefore, it is interesting to
note that tyrosine YXXPHI motifs are present in cytoplasm
residues of both the F and G glycoproteins of RSV [11].
The present findings indicate that specific antibody
bounded to the surface of RSV infected cell modify cell-
surface viral determinants, the intracellular viral polypep-
tide concentration and interfere with viral induced
destruction of the cell.
Alterations of RSV intracellular viral proteins expression
by anti-RSV IgG interaction with cell-surface viral glyco-
proteins is reminiscent with reports in the measles virus
system, where expression of intracellular viral proteins is
modify by the interaction of specific antibodies with cell-
surface viral glycoproteins [5]. Measles virus like RSV is a
member of the Paramyxoviridae family [40].
How these processes are involved in the viral life cycle and
viral pathogenesis is unknown, however, increase in viral
replication with concomitant enhance of the disease [17-
19] might be related to RSV Ag-Abs induced delay on cell
destruction. Furthermore, retrieval of RSV envelope pro-
teins from the cell-plasma membrane lowers the amount
of viral determinants that are exposed at the cell surface,
and may therefore reduce the efficiency of recognition by
the immune system favouring viral persistence in the
organism [5,41]. Virus to persist must evade immune sur-
veillance and not kill the host cell [42].
To our knowledge, this is the first report on antibody-
induced modulation of respiratory syncytial virus anti-
gens. Moreover, the system we described allows study
long time interaction between RSV infected cells and anti-
viral antibodies.
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Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
RES and RT contributed in the experimental work, analy-
sis of results and discussion of results. LV performed the
majority of the experimental work and BG conceived and
wrote the manuscript. All authors read and approved the
final manuscript
Acknowledgements
We are grateful to Andi Espinoza Sánchez and Xochitl Alvarado for their 
assistance with the confocal laser image assays. The authors also thank 
Veronica Yakoleff for editing the draft and Josefina Bolado for revising the 
Engish version of the manuscript. This work was partially funded by grants 
from Consejo Nacional de Ciencia y Tecnología (CONACYT; U-42867) 
and Dirección General de Apoyo al Personal Académico (DGAPA; IN 
203303), LV was supported from grant DGAPA; IN206400
References
1. Joseph BS, Oldstone MB: Immunologic injury in measles virus
infection. II. Suppression of immune injury through antigenic
modulation.  J Exp Med 1975, 142(4):864-876.
2. Stackpole C, Jacobson J: Antigen modulation.  In The handbook of
cancer immunology Edited by: Waters H. New York, Barland STPM
Press; 1978:55-70. 
3. Dubois-Dalcq M, Hooghe-Peters EL, Lazzarini RA: Antibody-
induced modulation of rhabdovirus infection of neurons in
vitro.  J Neuropathol Exp Neurol 1980, 39(5):507-22.
4. Chesebro B, Wehrly K, Doig D, Nishio J: Antibody-induced mod-
ulation of Friend virus cell surface antigens decreases virus
production by persistent erythroleukemia cells: influence of
the Rfv-3 gene.  Proc Natl Acad Sci USA 1979, 76(11):5784-5788.
5. Fujinami RS, Sissons JGP, Oldstone MB: Antibody-induced modu-
lation of viral antigens from infected cells: biological and
molecular studies of measles virus infection and implications
for understanding virus persistence and receptor diseases.  In
Animal Virus Genetics. ICN-UCLA Symposia on Molecular and Cellular Biol-
ogy Volume XVIII. Edited by: Fields B, Jaenisch R, Fox CF. Academic
Press, New York; 1980:769-775. 
6. Favoreel HW, Nauwynck HJ, Halewyck HM, Van Oostveldt P, Met-
tenleiter TC, Pensaert MB: Antibody-induced endocytosis of
viral glycoproteins and major histocompatibility complex
class I on pseudorabies virus-infected monocytes.  J Gen Virol
1999, 80:1283-1291.
7. Favoreel HW, Nauwynck HJ, Van Oostveldt P, Mettenleiter TC, Pen-
saert MB: Antibody-induced and cytoskeleton-mediated
redistribution and shedding of viral glycoproteins, expressed
on pseudorabies virus-infected cells.  J Virol 1997,
71(11):8254-8261.
8. Favoreel HW, Nauwynck HJ, Van Oostveldt P, Pensaert MB: Role of
anti-gB and -gD antibodies in antibody-induced endocytosis
of viral and cellular cell surface glycoproteins expressed on
pseudorabies virus-infected monocytes.  Virology 2000,
67(2):151-158.
9. Van de Walle GR, Favoreel HW, Nauwynck HJ, Van Oostveldt P, Pen-
saert MB: Antibody-induced internalization of viral glycopro-
teins in pseudorabies virus-infected monocytes and role ofPage 8 of 9
(page number not for citation purposes)
Virology Journal 2007, 4:68 http://www.virologyj.com/content/4/1/68Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
the cytoskeleton: a confocal study.  Vet Microbiol 2002,
22;86((1–2)):51-57.
10. Favoreel HW, Mettenleiter TC, Nauwynck HJ: Copatching and
lipid raft association of different viral glycoproteins
expressed on the surfaces of pseudorabies virus-infected
cells.  J Virol 2004, 78(10):5279-5287.
11. Collins PL, Chanok RM, Murphy BR: Respiratory syncytial virus.
In Fields virology 4th edition. Edited by: Knipe DM, Howley PM, Griffin
DE, Lamb RA, Martin MA, Roizman B, Straus SE. Lippincott Williams
& Wilkins, Philadelphia, Pa; 2001:p1443-1485. 
12. Fuentes S, Tran KC, Luthra P, Teng MN, He B: Function of the Res-
piratory Syncytial Virus small hydrophobic protein.  J Virol  in
press. 2007 May 9
13. Hall CB, Hall WJ, Gala CL, MaGill FB, Leddy JP: Long term pro-
spective study in children after respiratory syncytial virus
infection.  J Pediatr 1984, 105:358-364.
14. Ogra PL: Respiratory syncytial virus: the virus, the disease and
the immune response.  Paediatr Respir Rev 2004, 5(Suppl
A):119-126.
15. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE: Respira-
tory syncytial virus infection in elderly and high-risk adults.  N
Engl J Med 2005, 352:1749-1759.
16. Ebbert JO, Limper H: Respiratory syncytial virus pneumonitis in
immunocompromised adults: clinical features and outcome.
Respiration 2005, 72:263-269.
17. Durbin JE, Durbin RK: Respiratory Syncytial Virus-Induced
immuneprotection and Immunopathology.  Viral Immunology
2004, 17:370-380.
18. Openshaw PJM, Tregoning JS: Immune responses and Disease
Enhancement during respiratory Syncytial Virus Infection.
Clinical microbiology Reviews 2005, 18:541-555.
19. Hoffman SJ, Laham FR, Polack FP: Mechanisms of illness during
respiratory syncytial virus infection: the lungs, the virus and
the immune response.  Microbes Infect 2004, 6(8):767-772.
20. Openshaw PJ, Yamaguchi Y, Tregoning JS: Childhood infections,
the developing immune system, and the origins of asthma.  J
Allergy Clin Immunol 2004, 114:1275-1277.
21. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory
syncytial virus bronchiolitis in infancy is an important risk
factor for asthma and allergy at age 7.  Am J Respir Crit Care Med
2000, 161:150-157.
22. Papadopoulos NG, Kalobatsou A: Respiratory viruses in child-
hood asthma.  Curr Opin Allergy Clin Immunol 2007, 7(1):91-95.
23. Martin Mateos MA: Respiratory syncytial virus infection and
asthma.  Allergol Immunopathol 2001, 29(3):140-146.
24. Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha
JA: Respiratory syncytial virus, airway inflammation, and
FEV1 decline in patients with chronic obstructive pulmonary
disease.  Am J Respir Crit Care Med 2006, 173(8):871-876.
25. Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H, Lir-
man DD, Rabold R, Hoffman SJ, Karp CL, Kleeberger SR, Wills-Karp
M, Karron RA: A role for immune complexes in enhanced res-
piratory syncytial virus disease.  J Exp Med 2002, 196(6):859-65.
26. Openshaw PJ, Tregoning J, Harker J: RSV 2005: Global impact,
changing concepts, and new challenges.  Viral Immunol 2005,
18:749-751.
27. Schwarze J, O'Donnell DR, Rohwedder A, Openshaw PJ: Latency
and persistence of respiratory syncytial virus despite T cell
immunity.  Am J Respir Crit Care Med 2004, 169:801-805.
28. Ostler T, Hussell T, Surh CD, Openshaw P, Ehl S: Long-term per-
sistence and reactivation of T cell memory in the lung of
mice infected with respiratory syncytial virus.  Eur J Immunol
2001, 31(9):2574-2582.
29. Scott PD, Ochola R, Ngama N, Okiro EA, Nokes DJ, Medley GF,
Cane PA: Molecular analysis of respiratory syncytial virus
reinfections in infants from coastal Kenya.  J Infect Dis 2006,
193:59-67.
30. Stensballe LG, Devasundaram JK, Simoes EA: Respiratory syncytial
virus epidemics: the ups and downs of a seasonal virus.  Pediatr
Infect Dis J 2003, 22(Suppl 2):21-32.
31. Monto AS: Occurrence of respiratory virus: time, place and
person.  Pediatr Infect Dis J 2004, 23(Suppl 1):58-64.
32. Sarmiento RE, Tirado R, Gomez B: Characteristics of a respira-
tory syncytial virus persistently infected macrophage-like
culture.  Virus Res 2002, 84:45-58.
33. Garcia-Barreno B, Jorcano JL, Aukenbauer T, Lopez-Galindez C,
Melero JA: Participation of cytoskeletal intermediate fila-
ments in the infectious cycle of human respiratory syncytial
virus (RSV).  Virus Res 1988, 9(4):307-321.
34. Valdovinos MR, Gomez B: Establishment of respiratory syncy-
tial virus persistence in cell lines: association with defective
interfering particles.  Intervirology 2003, 46(3):190-198.
35. Harlow E, Lane D: Antibodies: A Laboratory Manual.  Cold Spring
Harbor Laboratory 1988:521-530.
36. Olson JK, Grose C: Endocytosis and recycling of varicella-
zoster virus Fc receptor glycoprotein gE: internalization
mediated by a YXXL motif in the cytoplasmic tail.  J Virol 1997,
71(5):4042-4054.
37. Mukherjee S, Ghosh RN, Maxfield FR: Endocytosis.  Physiol Rev 1997,
77(3):759-803.
38. Heuser JE, Anderson RG: Hypertonic media inhibit receptor-
mediated endocytosis by blocking clathrin-coated pit forma-
tion.  J Cell Biol 1989, 108(2):389-400.
39. Favoreel HW: The why's of Y-based motifs in alphaherpesvirus
envelope proteins.  Virus Res 2006, 117(2):202-8.
40. Lamb RA, Kolakofsky D: Paramixoviridae: the virus and their
replication.  In Fundamental virology 4th edition. Edited by: Knipe
DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus
SE. Lippincott Williams & Wilkins, Philadelphia, Pa; 2001:p689-724. 
41. Fujinami RS, Oldstone MB: Antigenic modulation: a mechanism
of viral persistence.  Prog Brain Res 1983, 59:105-111.
42. Oldstone MB: Viral persistence: parameters, mechanisms and
future predictions.  Virology 2006, 344(1):111-118.Page 9 of 9
(page number not for citation purposes)
